Search for content, post, videos

3 Stocks in the Spotlight with Their Technical: Novavax, (NASDAQ:NVAX), Resolute Energy (NYSE:REN),Yingli Green Energy (NYSE:YGE)

Yingli Green Energy Holding Co Ltd (ADR) (NYSE:YGE) one of the world’s leading solar panel manufacturers, today announced that its holding subsidiary, Baoding Tianwei Yingli New Energy Company Limited (“Tianwei Yingli”), plans to restructure the repayment plan for $157 million USD (1.0 billion RMB) of mid-term notes (“MTNs”) due on October 13, 2015. The MTNs were issued by Tianwei Yingli as five-year unsecured notes. The Company expects to receive approximately $138 million USD (875 million RMB) as the compensation (“the Compensation”) from the liquidation of idle land and demolition of facilities held by Fine Silicon, one of the Company’s wholly-owned subsidiaries. The Company believes it will be able to collect a substantial amount of the Compensation to partially repay the MTNs before the end of 2015. The remaining amount of the MTNs is expected to be repaid within one year, and will be collected from various financing sources, including the Company’s collection of accounts receivables.
Shares of YGE plunged 181.76M to end last trade at 0.328.

Technical Indicators:

  • The current support level is placed at $27and the stock is finding resistance at $ 0.45.
  • 80% Barchart technical sell signal
  • Trend Spotter sell signal
  • Moving average direction is bearish/bullish as trades above its -78.55%, -56.24%, -42.15% day SMA
  • Rose -86.03% so far this year but gained -58.96%in the past month and is down -28.63% for the week
  • Relative Strength Index (RSI) stands at 46.

 

Novavax, Inc. (NASDAQ:NVAX)  a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 1 clinical trial of its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in healthy children. The trial was a randomized, observer-blinded, Phase 1 study to evaluate the safety and immunogenicity of the RSV F Vaccine, with one or two doses, with or without aluminum phosphate adjuvant, in healthy pediatric participants two to six years of age. The trial’s primary goal was to evaluate safety in this population and immunogenicity as measured by concentrations of serum IgG antibodies to the RSV fusion, or F-protein, palivizumab-competing antibody (PCA) titers and RSV microneutralization titers. Novavax concluded this trial’s enrollment with a smaller than planned cohort so dosing could be completed ahead of the 2014-2015 RSV season.

Technical Indicators:

  • The current support level is placed at $86 and the stock is finding resistance at $ 9.20.
  • 100% Barchart technical sell signal
  • Trend Spotter sell signal
  • Moving average direction is bullish/bearish as trades above its -30.13%, -43.22%, -35.82% day SMA.
  • Dropped 09% so far this year but plunged -44.84% in the past month and is down -34.39%for the week
  • Relative Strength Index (RSI) stands at 00.

Resolute Energy Corp (NYSE:REN) today announced that it has commenced a limited marketing process for its Gardendale property in Midland and Ector counties, Texas in the Permian Basin. The Company will assess market feedback and potential valuation, among other factors, in determining whether or not to pursue a sale of some or all of its interest in the property. The Company has engaged Petrie Partners, LLC and BMO Capital Markets as financial advisors in connection with this transaction.
Shares of REN plunged 77.51M to end last trade at $ 0.353.

Technical Indicators:

  • The current support level is placed at $28 and the stock is finding resistance at $ 0.50.
  • 100% Barchart technical sell signal
  • Trend Spotter sell signal
  • Moving average direction is bullish/bearish as trades above its -61.21%, -32.69%, -28.01% day SMA.
  • Dropped -73.23% so far this year but plunged -23.29% in the past month and is down -31.76%for the week
  • Relative Strength Index (RSI) stands at 50.